| CAHR Abstracts 2002 |
BASIC SCIENCES / SCIENCES FONDAMENTALES
ORAL PRESENTATIONS / PRÉSENTATIONS ORALES
CYTOKINES
[122] INTERLEUKIN (IL-7) AND THYMIC
OUTPUT LEVELS DURING PRIMARY HIV-INFECTION
JP Routy1, MR Boulassel1, M Sylvestre2,
JF Poulin2, RP Sekaly2, R Cheynier2
1Division of Hematology, McGill University Health Centre and 2Department
of Immunology, University of Montreal, Montreal, Quebec
[123] INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) AND
INTERLEUKIN-7 (IL-7) LEVELS DURING PRIMARY AND EARLY PHASE OF HIV INFECTION:
CORRELATION WITH IMMUNE AND VIRAL PARAMETERS
MR Boulassel1, M Legault2, M Lainesse2,
PR Sekaly2, JP Routy1, the Investigators of the Montreal
Primary HIV Infection Cohort
1Immunodeficiency Service, McGill University Health Centre, Royal
Victoria Hospital, McGill University; 2Department of Microbiology
and Immunology, University of Montreal, Montreal, Quebec
[124] INTERLEUKIN-7 RECEPTOR (CD127)
EXPRESSION AND RNA ACCUMULATION IN CD8+ T CELLS IS DOWNREGULATED BY TNF-a
A Komsic*, JB Angel
Ottawa Health Research Institute, Ottawa, Ontario
[125] SYSTEMIC LEVELS OF TYPE-1
(IP-10 AND MIG), AND TYPE-2 (TARC, MDC AND EOTAXIN) CHEMOKINES IN HIV-1 HIGHLY
EXPOSED, PERSISTENTLY SERONEGATIVE (HEPS) AND HIV INFECTED SEX WORKERS FROM
NAIROBI, KENYA
TB Ball1, J Kimani2, JE Embree3,
JJ Bwayo2, FP Plummer2,3, KT HayGlass1,3
Departments of 1Immunology, and 3Medical Microbiology,
University of Manitoba; 2Department of Medical Microbiology, University
of Nairobi, Kenya
[126] ENHANCED
IL-10 RESPONSES BY A CD36+ MONONUCLEAR CELL SUBSET FROM HIV-INFECTED INDIVIDUALS
L Barrett, J Gamberg, MI Bowmer, C Nguyen, C Howley, M Grant
Immunology Program, Memorial University of Newfoundland, St John’s, Newfoundland
[127]
ADENOSINE A2A RECEPTOR INHIBITS TNF-a PRODUCTION INDUCED BY Tat BY BLOCKING
CALCIUM RELEASE FROM IP3 RECEPTORS VIA PROTEIN PHOSPHATASE
M Mayne*1,2, J Fotheringham1,2, C Holden1,
A Nath3, JD Geiger1,2
1Department of Pharmacology and Therapeutics, University of Manitoba,
Winnipeg, Manitoba; Division of Neurovirology and Neurodegenerative Disorders,
St Boniface Hospital Research Centre, Winnipeg, Manitoba; 3Department
of Neurology, 2Microbiology and Immunology, Lexington, Kentucky